Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06127654

Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy

VITaL: A Randomised Controlled Trial Investigating Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy

Status
Not Yet Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
165 (estimated)
Sponsor
University of Sydney · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This research project is testing a new treatment planning method for patients with lung cancer who will be treated with radiation therapy. This new method is called Computed Tomography (CT) ventilation imaging. It aims to help protect the healthiest parts of patient's lungs from being injured by the radiation therapy. The investigators will determine whether healthy lung sparing can improve the quality of life in these patients.

Detailed description

The planning and delivery of Radiation Therapy (RT) is a balance between delivering a curative dose to the tumour while sparing healthy organs, such as the lungs, from collateral damage such as pneumonitis. To minimise radiation-induced lung injury, our team has invented and pioneered ventilation imaging based on Computed Tomography (CT). This Australian-invented medical device, now an international field of research, uses CT scans routinely acquired for planning RT to compute a CT ventilation map showing high functioning and low functioning lung regions. This image is used as the basis for directing radiation away from the healthy, high functioning regions towards the low functioning regions, thereby aiming to reduce toxicity and improve the patient's quality of life.

Conditions

Interventions

TypeNameDescription
DEVICEHealthy lung sparing treatment planCT Ventilation imaging will be used to create a healthy lung sparing treatment plan for patients who will receive radiation therapy treatment for their lung cancer.

Timeline

Start date
2025-05-01
Primary completion
2028-12-01
Completion
2028-12-01
First posted
2023-11-13
Last updated
2025-04-04

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT06127654. Inclusion in this directory is not an endorsement.